双嘧达莫联合甲氰咪胍治疗小儿病毒性腹泻临床疗效及安全性探讨

摘要

Objective To explore the treatment of infantile viral diarrhea patients, in the process of using dipyridamole coalition armor cyanogen mi guanidine two bed, efficacy, and safety.MethodsRandomly in April 2013 - December 2014 to the hospital treatment of 50 cases of patients with infantile viral diarrhea, using computer to its average divided into observation group and control group, each group has 25 patients. Drugs used in the control group with during the treatment of ribavirin, observation group of patients during treatment drugs used for armor cyanogen dipyridamole union mi guanidine. Contrast the curative effect of two groups of patients and adverse reactions occur.Results Two groups of patients with different drug treatment, the treatment of patients with observation group, the total effective rate of 96% 84% is signiifcantly higher than the control group (P<0.05).Conclusion In patients with infantile viral diarrhea with treatment process, the use of dipyridamole coalition armor cyanogen guanidine treatment, not only can improve the treatment effect of patients, but also can reduce the incidence of adverse reactions, has the high security, recommend the clinical application.%目的：探究在对小儿病毒性腹泻的患者进行治疗的过程中，采用双嘧达莫（潘生丁）联合甲氰咪胍的临床效果以及安全性。方法随机抽取2013年4月～2014年12月来我院治疗的患有小儿病毒性腹泻的患者50例，利用计算机将其平均分为观察组与对照组，每组各有25例患者。对照组患在接受治疗期间所用的药物为病毒唑，观察组患者在接受治疗期间使用的药物为潘生丁联合甲氰咪胍。对比两组患者的治疗效果以及治疗期间的各项指标。结果两组患者使用不同的药物治疗后，观察组患者的治疗总有效率为96%，高于对照组的84%（P＜0.05）；观察组患者治疗期间的相关指标优于对照组（P＜0.05）。结论在对小儿病毒性腹泻的患者施以治疗的过程中，使用潘生丁联合甲氰咪胍治疗，不仅可以提高患者的治疗效果，同时还可以降低不良反应的发生率，安全性高。